Insider Selling: MedEquities Realty Trust Inc (MRT) Director Sells 10,000 Shares of Stock

MedEquities Realty Trust Inc (NYSE:MRT) Director Bluemountain Capital Managemen sold 10,000 shares of the stock in a transaction on Friday, October 12th. The stock was sold at an average price of $8.74, for a total transaction of $87,400.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Bluemountain Capital Managemen also recently made the following trade(s):

  • On Thursday, November 8th, Bluemountain Capital Managemen sold 35,783 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.60, for a total transaction of $307,733.80.
  • On Tuesday, November 6th, Bluemountain Capital Managemen sold 25,765 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.58, for a total transaction of $221,063.70.
  • On Friday, November 2nd, Bluemountain Capital Managemen sold 25,000 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.39, for a total transaction of $209,750.00.
  • On Wednesday, October 31st, Bluemountain Capital Managemen sold 10,000 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.45, for a total transaction of $84,500.00.
  • On Monday, October 29th, Bluemountain Capital Managemen sold 11,695 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.39, for a total transaction of $98,121.05.
  • On Thursday, October 25th, Bluemountain Capital Managemen sold 25,546 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.45, for a total transaction of $215,863.70.
  • On Monday, October 22nd, Bluemountain Capital Managemen sold 5,463 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.65, for a total transaction of $47,254.95.
  • On Friday, October 19th, Bluemountain Capital Managemen sold 5,000 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.54, for a total transaction of $42,700.00.
  • On Wednesday, October 17th, Bluemountain Capital Managemen sold 23,200 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.84, for a total transaction of $205,088.00.
  • On Monday, October 15th, Bluemountain Capital Managemen sold 21,289 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.80, for a total transaction of $187,343.20.

Shares of NYSE:MRT traded up $0.11 during midday trading on Friday, hitting $8.73. The company’s stock had a trading volume of 170,034 shares, compared to its average volume of 126,070. The company has a market cap of $271.79 million, a P/E ratio of 7.66 and a beta of 0.65. MedEquities Realty Trust Inc has a 12-month low of $8.25 and a 12-month high of $12.00.

MedEquities Realty Trust (NYSE:MRT) last posted its quarterly earnings results on Friday, November 9th. The financial services provider reported ($0.07) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.28 by ($0.35). The business had revenue of $9.68 million during the quarter, compared to analysts’ expectations of $17.72 million. MedEquities Realty Trust had a return on equity of 5.73% and a net margin of 30.84%. As a group, analysts expect that MedEquities Realty Trust Inc will post 1.08 earnings per share for the current year.

A number of institutional investors have recently added to or reduced their stakes in MRT. JPMorgan Chase & Co. increased its position in MedEquities Realty Trust by 221.9% during the first quarter. JPMorgan Chase & Co. now owns 19,898 shares of the financial services provider’s stock worth $210,000 after purchasing an additional 13,717 shares during the last quarter. Dimensional Fund Advisors LP increased its position in MedEquities Realty Trust by 143.0% during the first quarter. Dimensional Fund Advisors LP now owns 74,932 shares of the financial services provider’s stock worth $787,000 after purchasing an additional 44,097 shares during the last quarter. Sei Investments Co. increased its position in MedEquities Realty Trust by 63.0% during the first quarter. Sei Investments Co. now owns 303,873 shares of the financial services provider’s stock worth $3,194,000 after purchasing an additional 117,397 shares during the last quarter. GSA Capital Partners LLP increased its position in MedEquities Realty Trust by 101.2% during the first quarter. GSA Capital Partners LLP now owns 65,800 shares of the financial services provider’s stock worth $692,000 after purchasing an additional 33,100 shares during the last quarter. Finally, Allianz Asset Management GmbH acquired a new stake in MedEquities Realty Trust during the first quarter worth about $254,000. Hedge funds and other institutional investors own 91.02% of the company’s stock.

Several equities analysts have issued reports on MRT shares. Zacks Investment Research raised shares of MedEquities Realty Trust from a “hold” rating to a “buy” rating and set a $13.00 price objective on the stock in a report on Wednesday, July 25th. KeyCorp downgraded shares of MedEquities Realty Trust from an “overweight” rating to a “hold” rating and set a $12.00 price objective on the stock. in a report on Wednesday, August 8th. ValuEngine downgraded shares of MedEquities Realty Trust from a “sell” rating to a “strong sell” rating in a report on Wednesday, August 8th. Canaccord Genuity decreased their price objective on shares of MedEquities Realty Trust from $13.00 to $12.00 and set an “overweight” rating on the stock in a report on Thursday, August 9th. Finally, B. Riley set a $12.00 price objective on shares of MedEquities Realty Trust and gave the company a “buy” rating in a report on Thursday, August 9th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. MedEquities Realty Trust currently has a consensus rating of “Hold” and an average price target of $11.25.

ILLEGAL ACTIVITY WARNING: This report was first posted by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this report on another domain, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this report can be accessed at https://www.baseballdailydigest.com/2018/11/10/insider-selling-medequities-realty-trust-inc-mrt-director-sells-87400-00-in-stock.html.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Read More: Why is Cost of Capital Important?

Insider Buying and Selling by Quarter for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply